We are live on ! Find out more
RXDX

Prometheus Biosciences, Inc. Common Stock
RXDX

Delisted

RXDX was delisted on the 15th of June, 2023.

Back to rankings

2 hedge funds and large institutions have $1.98M invested in Prometheus Biosciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 216 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% less call options, than puts

Call options by funds: $13.6M | Put options by funds: $51.5M

99% less funds holding

Funds holding: 219 → 2 (-217)

100% less capital invested

Capital invested by funds: $4.35B → $1.98M (-$4.35B)

100% less funds holding in top 10

Funds holding in top 10: 13 → 0 (-13)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 216

Holders
2
Holders Change
-217
Holders Change %
-99.09%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-13
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
216
Calls
$13.6M
Puts
$51.5M
Net Calls
-$37.9M
Net Calls Change
-$118M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$351M
2
BlackRock
BlackRock
New York
-$300M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$292M
4
BC
Boxer Capital
California
-$204M
5
7IH
72 Investment Holdings
Connecticut
-$198M
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
101
Boothbay Fund Management
New York
– -$2.59M -24,121 Closed
Jane Street
102
Jane Street
New York
– -$2.59M -24,089 Closed
Corient Private Wealth
103
Corient Private Wealth
Florida
– -$2.58M -24,076 Closed
Tudor Investment Corp
104
Tudor Investment Corp
Connecticut
– -$2.47M -22,989 Closed
SG Americas Securities
105
SG Americas Securities
New York
– -$2.4M -22,321 Closed
SSA
106
Schonfeld Strategic Advisors
New York
– -$2.37M -22,068 Closed
Prudential Financial
107
Prudential Financial
New Jersey
– -$2.32M -21,592 Closed
State of Wisconsin Investment Board
108
State of Wisconsin Investment Board
Wisconsin
– -$2.3M -21,463 Closed
TCM
109
Tang Capital Management
California
– -$2.25M -21,000 Closed
HS
110
HighVista Strategies
Massachusetts
– -$2.25M -20,955 Closed
MCM
111
Moore Capital Management
New York
– -$2.19M -20,381 Closed
JGC
112
J. Goldman & Co
New York
– -$2.18M -20,301 Closed
State of New Jersey Common Pension Fund D
113
State of New Jersey Common Pension Fund D
New Jersey
– -$2.14M -19,932 Closed
CS
114
Credit Suisse
Switzerland
– -$2.04M -19,049 Closed
Mirae Asset Global Investments
115
Mirae Asset Global Investments
South Korea
– -$2M -18,604 Closed
TC
116
TwinBeech Capital
New York
– -$1.99M -18,546 Closed
MIM
117
MetLife Investment Management
New Jersey
– -$1.97M -18,318 Closed
Wells Fargo
118
Wells Fargo
California
– -$1.96M -18,300 Closed
Squarepoint
119
Squarepoint
New York
– -$1.88M -17,550 Closed
AIG
120
American International Group
New York
– -$1.8M -16,793 Closed
GTC
121
Ghost Tree Capital
New York
– -$1.61M -15,000 Closed
NSEDCP
122
NJ State Employees Deferred Compensation Plan
New Jersey
– -$1.61M -15,000 Closed
DekaBank Deutsche Girozentrale
123
DekaBank Deutsche Girozentrale
Germany
– -$1.54M -14,300 Closed
GC
124
Guggenheim Capital
Illinois
– -$1.51M -14,103 Closed
SCM
125
Silverarc Capital Management
Massachusetts
– -$1.49M -13,921 Closed
3 4
5
6 7

RXDX Hedge Fund Activity: Q2 2023 in Review

2 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Prometheus Biosciences, Inc. Common Stock (RXDX) for Q2 2023, worth a combined $1.98M — down 100% from $4.35B a quarter earlier.

Sellers outnumbered buyers: 216 funds closed out of RXDX and 0 opened new positions — a net loss of 216 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RTW Investments, exiting entirely with an estimated $351M sold.

  • 2 institutional investors held Prometheus Biosciences, Inc. Common Stock (RXDX) as of Q2 2023, down from 219 in Q1 2023.
  • Funds reported $1.98M of Prometheus Biosciences, Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Prometheus Biosciences, Inc. Common Stock positions in Q2 2023 and 216 closed out, a net change of -216 holders.
  • The largest Prometheus Biosciences, Inc. Common Stock seller in Q2 2023 was RTW Investments, an estimated $351M sold.

Based on aggregated 13F filings for Q2 2023.